Sex, IBD hospitalisation, IBD surgery, and type 2 diabetes duration were equally distributed amongst patients exposed to GLP-1 receptor agonists and/or DPP-4 inhibitors and patients exposed to other antidiabetic drugs during follow-up
The FDAs position, stated explicitly in warning letters, is that RUO disclaimers are a ruse to avoid FDA scrutiny. If a product is being marketed in a way that implies human use through claim language, testimonials, dosing guidance, or the product category itself the disclaimer is legally irrelevant
Enzymes associated with certain tumors can act on the peptide structure or ester bonds of nanocarrier to release the loaded drug at targeted site [46, 51]
We would like to inform you that due to inventory, orders placed from 30.12.2025 to 09.01.2026, will be processed from 12.01.2026